(Q38005946)

English

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

scientific article published on 27 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jean-Baptiste Bachet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Marie Beylot-Barry

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Z Reguiai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

C Bachmeyer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

L Peuvrel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M Bezier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

E Boucher

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

C Chevelle

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

P Colin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

R Guimbaud

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

L Mineur

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M A Richard

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

P Artru

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

P Dufour

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

J M Gornet

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

E Samalin

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

R J Bensadoun

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

B Dreno

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

O Bouché

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

27 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1395-1404

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

EGFR inhibitor-associated acneiform folliculitis: assessment and management

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Cetuximab-induced acne

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Aprepitant for erlotinib-induced pruritus

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1451-6

21 January 2018

Pathology and management of dermatologic toxicities associated with anti-EGFR therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management of EGFRI dermatologic toxicities: the European perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management of EGFRI dermatologic toxicities: US perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Description and management of cutaneous side effects during erlotinib and cetuximab treatment in lung and colorectal cancer patients: a prospective and descriptive study of 19 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of gefitinib-associated folliculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trichomegaly of the eyelashes following treatment with cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Targeted biotherapies in digestive oncology: management of adverse effects]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-012-1451-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539049%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38005946&oldid=2201163960"